Santu Bandopadhyay

Title: Santu Bandopadhyay: Innovator in Anti-Diabetic Research

Introduction

Santu Bandopadhyay is a notable inventor based in Kolkata, India. He has made significant contributions to the field of diabetes research, particularly in developing innovative methods for treating type II diabetes. His work focuses on utilizing herbal extracts to enhance insulin signaling pathways.

Latest Patents

Santu Bandopadhyay holds a patent for "Herbal extract and compound lupinoside and its analogues as anti-diabetic type II drugs from plant Pueraria tuberosa." This invention relates to a method of preventing and treating type 2 diabetes. It also involves augmenting Glut4 phosphorylation and Glut4 translocation to target cell membranes, thereby enhancing insulin signaling in the transduction pathway. The patent outlines a simplified and cost-effective process for obtaining the extract and its active n-butanol fraction, specifically the active molecule Lupinoside PA (LPA), which is useful in preventing and treating diabetes type 2. Additionally, it includes a pharmaceutical composition derived from this process.

Career Highlights

Santu Bandopadhyay is affiliated with the Council of Scientific and Industrial Research, where he conducts his research and development activities. His work has garnered attention for its potential impact on diabetes treatment, showcasing his commitment to advancing medical science.

Collaborations

He collaborates with notable colleagues, including Debleena Dey and Swapan Kumar Mandal, who contribute to his research endeavors. Their combined expertise enhances the quality and scope of their projects.

Conclusion

Santu Bandopadhyay's innovative work in the field of anti-diabetic research exemplifies the importance of herbal medicine in modern healthcare. His contributions are paving the way for new treatment options for type II diabetes, demonstrating the potential of natural compounds in medical applications.